BusinessEarth Science Tech Enters Negotiations for MSN-2 and Nanoderm Distribution in Three Countries and Plans New Clinical Study with HIV-Seropositive and AIDS PatientsBy Nasdaq OMXNov 30, 2017, 1:01 PM UTC